Reality beat their plan and they're leaning in: recent realized upside surprise, response underway, drivers still live
The model's full reasoning — Q3 2018 call → NOWe need answer YES or NO. Need analyze transcript for three parts: realized favorable surprise vs company's own expectation, response already visible, cause still running. Let's parse. Key events: TIBSOVO launch, sales $4.5M first partial quarter. Steve says "we are pleased with progress" but does he say better than expected? He says "we are encouraged with steady growth" "awareness already above 90%, compares favorably to 50% awareness of IDHIFA at similar time" "we estimate over 100 unique prescribers" "pleased with uptake" "pleased with payer response" "not aware of any payer-related coverage issues." But no explicit "better than expected" or "ahead of expectations" regarding TIBSOVO. He says "This payer split is largely consistent with what we have seen with IDHIFA and what we expected prior to launch." So not better than expected. Other: AGILE trial accelerated enrollment completion from prior guidance. Chris: "we've been able to accelerate our AML frontline strategy... FDA confirmed EFS acceptable... study design revised to reduce number of patients... expect complete enrollment in 2020, a year earlier than prior guidance." This is a favorable surprise? It's a change due to FDA agreement and revised design. Did it exceed company's own expectation? They say "we now expect" earlier than prior guidance. That is a timeline improvement, but is it a realized favorable surprise? It's a plan change, not actual events. Also response: they are amending protocol. Cause still running? Not really. It's a regulatory/design change, not a demand/operational surprise. Another: sNDA for newly diagnosed AML, FDA accepted Real-Time Oncology Review Pilot. Not a surprise. Another: AG-270 pharmacodynamic markers "we are seeing expected effects" - not better. Another: Mitapivat enrollment "we anticipate completing enrollment in both trials in 2019" - no surprise. Another: IDHIFA won Prix Galien - not a surprise. Another: "we have submitted IND for AG-636" - no. Question asks: "does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favorable surprise in some visible way, with the cause of the surprise described as still in effect rather than finished?" Need find any instance.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SFIX | Stitch Fix, Inc. | Q3 2024 | 2024-06-04 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CTRA | Coterra Energy Inc. | Q1 2024 | 2024-05-03 | A |
| CW | Curtiss-Wright Corporation | Q1 2024 | 2024-05-02 | B+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| JPM | JPMorgan Chase & Co. | Q2 2021 | 2021-07-13 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| TPB | Turning Point Brands, Inc. | Q1 2017 | 2017-05-11 | B |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| CGNX | Cognex Corporation | Q2 2016 | 2016-08-01 | A |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| SAN | Banco Santander, S.A. | Q4 2015 | 2016-01-27 | B |
TENB · Q2 2021 → YESThe question is about whether management recounts something real that turned out better than expected, and they're already responding to it, with the cause still in effect. YES The transcript shows management describing the Alsid acquisition as delivering a realized favorable surprise: customers and prospects received the identity and user permission vulnerability assessment "well received" and it led to "outperformance of our earlier expectations from the business." This concerns a real operating event (customer adoption and platform uptake) that already happened and exceeded the company's own prior expectations. Management is visibly responding by accelerating investments: they plan to continue adding quota capacity in the second half (more than in the first half) and to invest in sales and marketing, explicitly tied to the strong performance and confidence in the business.
CYBR · Q3 2021 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES Management describes a realized favorable surprise in the subscription transition: "we made strong progress and outperformed our expectations in the third quarter" and "subscription ARR growth accelerated to 131%," with "strong demand for our SaaS solutions" continuing to drive it. They are already responding visibly by accelerating the transition and realloc resources, resetting plans upward to exit by Q3 2022 instead of Q4, and raising the annual recurring revenue growth expectation from 35% to 37% based on record bookings. The cause remains in effect, as they note the acceleration and strong demand environment persisting into the year.
ET · Q2 2023 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES The transcript shows management describing a realized favorable surprise on the Enable acquisition: actual performance "exceed[s] anything that we ever expected," with results "significantly higher, a good probably 40% or 50% higher than what we were anticipating." They attribute part of the upside to ongoing commercial synergies being discovered daily as integration proceeds. Management is visibly responding by integrating the assets, actively identifying and implementing new commercial opportunities (new routes, blending, additions to move more throughput), and reallocating attention toward expanding volumes.